Spotlight Series: Dr Parthive Patel
As part of our CMM Spotlight Series, PhD students' Dora Bonini and Michaela Gregorova interview Dr Parthive Patel - a Sir Henry Dale Research Fellow in CMM.
News
Screening has a critical effect on reducing bowel cancer incidence in England
Screening has reduced the incidence of bowel cancer finds a new study jointly led by researchers from the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust.
Long Covid not caused by COVID-19 immune inflammatory response, new research finds
Long Covid, which affects nearly two million people in the UK (1), is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that immune activation may persist for months after COVID-19.
Summer Graduation 2023
It was fantastic to celebrate with our graduates for the Cellular and Molecular Medicine and Biomedical Sciences programmes along with their families and friends.
Festival of Nature 2023
On Saturday 10th June, CMM researchers had a stall at the Festival of Nature Barton Hill Family Day. The event was hosted at University of Bristol’s micro-campus site at the Barton Hill Wellspring settlement.
Raising a pint for science!
The tail end of May saw researchers Simon Eastham and Will Miller from the School of Cellular and Molecular Medicine involved in organising the Pint of Science festival in Bristol, alongside fellow scientists from across the university.
Silver Athena Swan success for the School of Cellular and Molecular Medicine
The School of Cellular and Molecular Medicine has been successful in their application for an Athena Swan Silver Award in April 2023.
CMM Research Away Day 2023
The School of Cellular and Molecular Medicine came together on 29 March 2023 to celebrate their latest research news and updates at their Annual Research Away Day.
Genetic causes of three previously unexplained rare diseases identified
Using a new computational approach developed to analyse large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues including the University of Bristol, have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterised by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness.
Strep A, infection and pandemic shifts - flexible research
Streptococcus pyogenes (also known as the Group A Streptococcus (GAS) or ‘Strep A’) is a bacterial pathogen which can cause a range of diseases from mild (e.g. impetigo, pharyngitis) to severe invasive (e.g. pneumonia, necrotizing fasciitis, sepsis) and severe post infection immune-related conditions (e.g. rheumatic fever, rheumatic heart disease). GAS is estimated to cause over 0.5 million deaths annually, and is one of the top 10 infectious causes of death globally.